Drugs Made In America Acquisition Corp. (DMAA)

NGM – Real Time Price. Currency in USD

10.60

0.00 (0.00%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

Total Revenue

Cost of goods sold

Gross Profit

Operating expenses (excl. COGS)

-3M

-280K

Operating Income

-3M

-280K

Non-operating income, total

Pretax income

-280K

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-280K

Drugs Made In America Acquisition Corp. (DMAA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Drugs Made In America Acquisition Corp. (DMAA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Drugs Made In America Acquisition Corp. (DMAA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Drugs Made In America Acquisition Corp. (DMAA)

Income Statement (Annual)

Income Statement (Annual)